Her-2/neu as Predictive Marker for Endocrine Therapy and Chemotherapy in Patients with Metastatic Breast Cancer

By Köstler Wolfgang J.   Zielinski Christoph C.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 73-84

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic and Predictive Impact of the HER-2/ neu Extracellular Domain (ECD) in the Serum of Patients Treated with Chemotherapy for Metastatic Breast Cancer

By Müller Volkmar   Witzel Isabell   Lück Hans   Köhler Günter   Minckwitz Gunther   Möbus Volker   Sattler Daniel   Wilczak Waldemar   Löning Thomas   Jänicke Fritz   Pantel Klaus   Thomssen Christoph  

Breast Cancer Research and Treatment, Vol. 86, Iss. 1, 2004-07 ,pp. : 9-18

Springer Publishing Company

Access to resources Recommend Favorite

HER-2/neu as a Predictive Marker in a Population of Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Single-agent Docetaxel

By Di Leo A.  

Breast Cancer Research and Treatment, Vol. 86, Iss. 3, 2004-08 ,pp. : 197-206

Springer Publishing Company

Access to resources Recommend Favorite

O6methylguanineDNA methyltransferase as a prognostic and predictive marker for basallike breast cancer treated with cyclophosphamidebased chemotherapy

By              

Oncology Letters, Vol. 7, Iss. 6, 2014-01 ,pp. : 1778-1784

Spandidos Publications

Access to resources Recommend Favorite

TrkC: A New Predictive Marker in Breast Cancer?

By Blasco-Gutierrez Maria Jesus   Jose-Crespo Isabel Julia San   Zozaya-Alvarez Enrique   Ramos-Sanchez Rafael   Garcia-Atares Natividad  

Cancer Investigation, Vol. 25, Iss. 6, 2007-09 ,pp. : 405-410

Informa Healthcare

Access to resources Recommend Favorite